** This original article was previously published on the Innovation Origins website, on April 16, 2021. The original article can be found here. **
IVD testing, unlike regular screening tests, no longer needs to be performed in a medical setting, such as a hospital.
In-vitro diagnostics (IVD) is playing an increasingly important role in medical diagnostics. However, IVD still lacks adequate regulation. The new European legislation, which classifies tests according to the risks for the individual and for society, is set to change this. Holland Innovative (HI) in the Dutch city of Twente, with years of experience and integral knowledge of product development, is already working on a training course for its customers.
IVD involves measuring all kinds of values in tissue, blood, urine or saliva samples outside of the human body. This is done, for example, by using sensors that are based on semiconductor nanotechnology, where the information from sensors is analyzed via algorithms. IVD tests no longer need to be performed in a medical setting, unlike regular tests in a hospital.
This offers a wide range of advantages. You can drastically reduce the pressure on medical services for one thing. Whereas specialists within traditional medical diagnostics, such as radiologists, work with enormous equipment, IVD is all about ‘miniaturization’. This means that the technology is becoming smaller and smaller. Which also makes it possible to carry out tests at home. Because the new measuring equipment fits into a chip, this technology is also referred to as a ‘lab-on-chip‘.